|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��֢��������ȱ�ݲ� |
|
�������� |
|
�������� |
| ��������������� | |
|
���� |
|
����� |
| PubMed | |
|
Article by |
|
Article by |
��֢��������ȱ�ݲ��������ƺͻ������ƵĽ�չ
����, �����
������ͨ��ѧ�ڶ�ҽԺƤ����, 700004
����ȱ�ݲ�������Ƥ������,��ΪƤ����ѧ�о�������֮һ����10����,����֢��������ȱ�ݲ����ӷ������ƺͻ��������о�ȡ����Ҫ��չ,������2000��,���û������Ƴɹ�����X������֢��������ȱ�ݲ�����,����Ϊ�ǻ������ƾ�����̱�����ķ��֡�������������֢��������ȱ�ݲ����ӷ������ƺͻ��������о���չ��
[2] Noguchi M,Yi H,Resanblatt HM,et al.Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.Cell,1993,73(1):147-157.
[3] Russell SM,Keegan AD,Harada N,et al.Interlenkin-2 receptor gamma chain:a functional component of the interleukin-4 receptor.Science,1993,262(5141):1880-1883.
[4] Jameson JL,et al.Principles of Molecular Medicine.1st ed,New York:Humana Press In,1998.249.
[5] Santisteban I,Arredondo-Vega FX,Kelly S,et al.Novel splicing,missense,and deletion mutations in seven adenosine deaminase-deficient patients with late/deLayed onset of combined immunedeficiency disease.Contribution of genotype to phenotype.J Clin Invest,1993,92 (5):2291-23O2.
[6] Russell SM,Tayebi N,Nakajima H,et al.Mutation of Jak3 in a patient with SCID:essential role of Jak3 in lymphoid development.Science,1995,270(5237):797-800.
[7] Puel A,Ziegler SF,Buckley RH,et al.Defective IL7R expression in T (-) B (+) NK (+) severe combined immunedeficiancy.Nat Genet,1998,20(4):394-397.
[8] Buckley,RH,Schiff SE,Schiff RI,et al.Hematopoiefic stem-cell trans-plantation for the treatment of severe combined immunodeficiency.N Engl J Med,1999,340(7):508-516.
[9] Blaese RM,Culver KW,Miner AD,et al.T lymphocyte-directed gene therapy for ADA-SCID:initial trial results after 4 years.Science,1995,270(5235):475-480.
[10] Bordignon C,Notarangelo LD,Nobili N,et al.Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunedeficient patients.Science,1995,270(5235):470-475.
[11] Kohn DB,Hershfield MS,Carbonaro D,et al.T lymphocytes with a nor-real ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34 + cells in ADA-deficient SCID neonates.Nat Med,1998,4(7):775-780.
[12] Cavazzana-Calvo M,Hacein-Bey S,de Saint Basile G,et al.Gene thera-py of human severe combined immunadeficiency (SCID)-X1 disease.Science,2000,288(5466):669-672.
[13] Buckley RH.Gene therapy for human SCID:dreams become reality.Nat Mad,2000,6(6):623-624.
[14] Kohn DB.Gene therapy for XSCID:the first success of gene therapy.Pe-diatr Res,2000,48(5):578.
[15] Stephenson J.Gene therapy trials show clinical efficacy.JAMA,2000,283(5):589-590.
[16] Anderson WF.Gene therapy.The best of times,the worst of times.Science.2000,288(5466):627-629.